Form 4: Crexendo CTO Exercises Stock Units and Sells Over 390,000 Shares in Pre-Arranged Transaction

Crexendo, Inc.'s Chief Technology Officer, David Tzat-kin Wang, exercised 392,610 non-qualified stock units and simultaneously sold an equal number of common shares for a significant profit, as disclosed in a recent SEC Form 4 filing.

Summary

• David Tzat-kin Wang, Crexendo, Inc.'s Chief Technology Officer, exercised 392,610 non-qualified stock units on May 28, 2025, at an exercise price of $0.91 per unit.
• Concurrently, Mr. Wang disposed of 392,610 shares of Crexendo common stock on May 28, 2025, at a price of $4.90 per share.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.
• Following these transactions, Mr. Wang's direct beneficial ownership of Crexendo common stock decreased from 838,605 shares (after exercise) to 445,995 shares (after sale).
• The non-qualified stock units had an exercisable date of June 1, 2021, and an expiration date of March 11, 2026.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the insider sale could be viewed negatively, it's a pre-planned transaction for profit-taking and equity management, which is a common occurrence and not necessarily indicative of negative company performance.

Positives

• The Chief Technology Officer realized a substantial profit by exercising stock units at $0.91 and selling the shares at $4.90, demonstrating the value of his equity compensation.
• The transaction was conducted under a Rule 10b5-1(c) plan, which suggests a pre-scheduled and transparent sale, rather than a reaction to immediate market conditions.

Negatives

• The sale of 392,610 shares by a key executive like the CTO could be perceived negatively by some investors, potentially signaling a lack of confidence or simply profit-taking.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

This Form 4 filing details a routine insider equity transaction, common across all industries for executives managing their compensation and equity holdings. It does not provide specific insights into broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: May react to the insider sale, potentially interpreting it as a signal, though the Rule 10b5-1 plan mitigates concerns of opportunistic selling.

Key Dates

Recommendation

Keywords

Crexendo, CXDO, Form 4, insider trading, stock transaction, Chief Technology Officer, David Tzat-kin Wang, stock options, share sale, beneficial ownership, Rule 10b5-1 plan